COMPARE · Reviewed July 29, 2026

PAM vs VMI

Verdict: Side-by-side breakdown using the Bull Rankings model. PAM scored 53.2, VMI scored 61.5 — VMI leads.
Compare another set
PAM
Pampa Energía S.A.
Conglomerates · Quality-Growth
53.2
$89.02 · $4.8B
fundamentals as of
Score gap
8.3
VMI leads
VMI
Valmont Industries, Inc.
Conglomerates · Quality-Growth
61.5
$473.95 · $9.1B
fundamentals as of
THE BULL RANKINGS SCORECARD53/ 100 · BULL SCOREPEER MEDIANQUALITY58GROWTH73VALUE36
THE BULL RANKINGS SCORECARD62/ 100 · BULL SCOREPEER MEDIANQUALITY80GROWTH42VALUE69
PAM
stronger →← stronger
VMI
58
Qualityreturns · margins · balance sheet
80
73
Growthrevenue & earnings expansion
42
36
Valuevaluation vs sector peers
69
VMI is stronger on 2 of 3 pillars.
PAM
VMI
-$12mF
FCF
$322mC
+8.3%B
Rev
+3.8%C+
0.50B+
D/E
0.50B+
2.6xB
P/S
1.58C+
PEG
1.13B+
P/E
18.5xA-
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
PAM
VMI
Price vs fair valuelower is cheaper
97% above
Growth the price implies10-yr FCF · lower = less priced in
~26%/yr
1-yr DCF upside
-55%
5-yr DCF upside
-49%
10-yr DCF upside
-40%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
PAM
No notable signals flagged.
VMI
Why this score
  • Buying back stock
  • Raising its dividend
PAMPampa Energía S.A.
Conglomerates · $89.02 · beta -0.22
Why now
Conglomerates · market cap $4.8b. 6% off the 52-week high of $94.50. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $117.59 (implying +32% upside).
Moat
Net margin 33% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Free cash flow is negative (-$12m) — capital raises or debt issuance likely required; dilution / leverage risk.
VMIValmont Industries, Inc.
Conglomerates · $473.95 · beta 1.33
Why now
Conglomerates · market cap $9.1b. 19% off the 52-week high of $585.71. 4 sell-side analysts rate this a Buy with a mean 1-yr target of $624.50 (implying +32% upside).
Moat
ROE 29% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.